BioCentury
ARTICLE | Financial News

CytomX raises $70M in series D

June 18, 2015 12:56 AM UTC

CytomX Therapeutics Inc. (South San Francisco, Calif.) raised $70 million in a series D round led by Fidelity Management and Research Co. Also participating were Casdin Capital; Cormorant Asset Management; Deerfield Management; Perceptive Advisors; Redmile Group; Tekla Healthcare; Tekla Life Science Investors; Venrock; Wellington Management; and undisclosed investors.

The company develops Probodies, which consist of an antibody, a peptide "mask" that blocks the antibody's active site, and an endogenous protease substrate that links the two and is cleaved in the presence of the appropriate protease to reveal an active antibody. ...